Patent · US Expired

N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

US5162328A · kind A · utility

2Cited by

1References

20Claims

0Family size

Assignee

American Cyanamid Company · US

Inventors

Rolf Paul · River Vale, US
Robert G. Kelly · Latham, US
Lawrence W. Torley · Washingtonville, US

Key dates

Filing date	Dec 31, 1991
Grant date	Nov 10, 1992
Priority date	—
Expiry date	Dec 31, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-[3-[2-(1H-Imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologicaly acceptable salts, useful as antiasthma agents and treatment of allergic diseases and exhibiting improved bioavailability properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.